In summary, our study identifies LCN2 as a key regulator in the TWEAK/Fn14 signaling pathway, impacting psoriasis lesion development, inflammatory cell infiltration, and release of inflammatory factors. This evidence concerns the gene TNFRSF12A and psoriasis.